NEW! If you don't understand one of the words in this article,
just double-click it.
A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature
doesn't work in your browser, you can enter the word below:
Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.
November 29, 2005
Kaletra Monotherapy Shows Promise Again
by Staff
November 29, 2005—In a small Spanish study, 81% of positive people maintained control of their HIV by taking Kaletra (a boosted protease inhibitor) alone for 72 weeks. The subjects in the study, reported last week at the Tenth European AIDS Conference in Dublin, had had undetectable HIV viral loads for at least six months on a combo of Kaletra and two nukes; then they stopped taking the nukes.